Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-07-03Prospective Multicenter, Non Interventional Study to Evaluate the Patient's Characteristics Associated With Adherence to Treatment Regimen by Betaferon in the BetaPlus Program
-
CLINICAL_TRIALS study record update · 2015-06-30ClinicalTrials.gov study NCT01720849
-
CLINICAL_TRIALS study record update · 2015-06-22TYGRIS: TYSABRI® Global Observational Program in Safety
-
CLINICAL_TRIALS study record update · 2015-06-09An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
-
CLINICAL_TRIALS study record update · 2015-06-03'Functioning and Disability' and 'Quality of Life' in an Australian Community Cohort With Multiple Sclerosis.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-06-01A Phase II, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Adaptive Dose-ranging Study to Evaluate the Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-06-01The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2015-05-13A Phase I, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and T-cell Tolerizing Effect of DC-TAB in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2015-05-12Methylphenidate Modified-release as Treatment of MS-associated Fatigue. A Single-center Randomized Double-blind Placebo-controlled Study.
-
CLINICAL_TRIALS study record update · 2015-05-12Does Adderall XR Improve Processing Speed in Cognitively Impaired MS Patients?
-
CLINICAL_TRIALS study record update · 2015-05-12Double-Blind, Randomized, Controlled, Cross-over Comparison of Efficacy and Safety of Botulinum Toxin Type A in the Targeted Treatment of Disabling Tremor in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-05-07Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-04-24Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit
-
CLINICAL_TRIALS study record update · 2015-04-21Intensity Depended Impact of a Single Exercise Bout on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study
-
CLINICAL_TRIALS study record update · 2015-04-17Evaluation of Cerebrovascular Hemodynamics With Transcranial Doppler and Near-infrared Spectroscopy in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-04-15Rehabilitating Extremity Use After Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-04-13TYGRIS - ROW: TYSABRI® Global Observational Program in Safety - Rest of World
-
CLINICAL_TRIALS study record update · 2015-04-09A Randomized Controlled Double-blind Cross-over Trial of Dalfampridine ER for Effect on Ambulatory Activity in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-04-07Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)
-
CLINICAL_TRIALS study record update · 2015-04-07Telephone Delivered Self-management Intervention for People With Multiple Sclerosis Addressing Pain, Fatigue, Depression, and Cognitive Difficulties
-
CLINICAL_TRIALS study record update · 2015-04-06A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-04-03Analysis of a Biomarker Signature, Consisting of Toll-like Receptor 2 (TLR2), TLR4 and CCR1, by Flow Cytometry in Patients With MS Treated With Gilenya (FTY720)
-
CLINICAL_TRIALS study record update · 2015-04-03Vascular Fundus Changes in Patients With High Probability of CCSVI (Chronic Cerebrospinal Venous Insufficiency)
-
CLINICAL_TRIALS study record update · 2015-03-27Group Balance Training for People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2015-03-25Extension of Protocol HMR1726D/2001, A Phase II Study of the Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses